First in Human Study of TORL-3-600 in Participants With Advanced Cancer
Clinical trial NCT05948826 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05948826
- Sponsor
- TORL Biotherapeutics, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-29
- Primary completion
- 2026-06-25
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.